Commerce Bank purchased a new position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 5,470 shares of the technology company’s stock, valued at approximately $887,000.
Other large investors have also recently bought and sold shares of the company. Danske Bank A S bought a new position in shares of Novanta during the 3rd quarter worth approximately $40,000. Allworth Financial LP lifted its position in shares of Novanta by 978.4% in the fourth quarter. Allworth Financial LP now owns 399 shares of the technology company’s stock worth $47,000 after purchasing an additional 362 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Novanta by 120.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock worth $51,000 after purchasing an additional 233 shares in the last quarter. ANTIPODES PARTNERS Ltd acquired a new position in Novanta during the fourth quarter worth $53,000. Finally, Harbor Investment Advisory LLC acquired a new position in Novanta during the second quarter worth $54,000. Institutional investors and hedge funds own 98.35% of the company’s stock.
Insiders Place Their Bets
In other Novanta news, CEO Matthijs Glastra sold 6,500 shares of the company’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the sale, the chief executive officer directly owned 29,761 shares of the company’s stock, valued at approximately $4,795,389.93. This represents a 17.93% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company’s stock.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Report on NOVT
Novanta Stock Up 3.1%
NASDAQ:NOVT opened at $143.96 on Thursday. The firm has a market capitalization of $5.44 billion, a price-to-earnings ratio of 92.28 and a beta of 1.68. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $176.38. The stock’s 50 day moving average price is $152.72 and its two-hundred day moving average price is $143.32. The company has a quick ratio of 3.79, a current ratio of 4.57 and a debt-to-equity ratio of 0.12.
Novanta (NASDAQ:NOVT – Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The technology company reported $0.89 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.83 by $0.06. The company had revenue of $265.81 million for the quarter, compared to analysts’ expectations of $262.30 million. Novanta had a return on equity of 10.83% and a net margin of 6.00%.The business’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.76 EPS. Novanta has set its FY 2026 guidance at 3.680-3.740 EPS and its Q3 2026 guidance at 0.950-1.000 EPS. Equities research analysts expect that Novanta Inc. will post 3.7 earnings per share for the current fiscal year.
Novanta Company Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Read More
- Five stocks we like better than Novanta
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
